Download PDF
Thromb Haemost 2006; 95(01): 190-191
DOI: 10.1055/s-0037-1612582
Case Report
Schattauer GmbH

Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome

Christina Rieger
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
,
Andreas Rank
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
,
Michael Fiegl
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
,
Johanna Tischer
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
,
Xaver Schiel
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
,
Helmut Ostermann
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
,
Hans-Jochem Kolb
1   Department of Internal Medicine III, University Hospital Grosshadern, Munich, Germany
› Author Affiliations
Further Information

Publication History

Received 01 July 2005

Accepted after resubmission 01 November 2005

Publication Date:
15 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Bernard J, Soulier J P. Sur une nouvelle varieté de dystrophie thrombocytairehemorrhagipare congenitale. Semin Hop Paris 1948; 24: 3217.
    PubMedGoogle Scholar
  • 2 Lopez JA, Andrews RK, Afshar-Kharghan V. et al. Bernard-Soulier-Syndrome. Blood 1998; 91: 4397-418.
    PubMedGoogle Scholar
  • 3 Caen JP, Levy-Toledano S. Interaction between platelets and von Willebrand factor provides a new scheme for primary haemostasis. Nat New Biol 1973; 244: 159-60.
    CrossrefPubMedGoogle Scholar
  • 4 Andrews RK, José A, Berndt MC. Molecular mechanisms of platelet adhesion and Activation. Int J Biochem Cell Biol 1997; 29: 91-105.
    CrossrefPubMedGoogle Scholar
  • 5 Cuthbert RJ, Watson HH, Handa SI. et al. DDAVP shortens the bleeding time in Bernard-Soulier syndrome. Thromb Res 1988; 49: 649-50.
    CrossrefPubMedGoogle Scholar
  • 6 Kehmali S, Canatan D, Uysal Z. et al. DDAVP shortens bleeding time in Bernard-Soulier syndrome. Thromb Haemost 1994; 71: 675.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Greinacher A, Pötzsch B, Kiefel V. et al. Evidence that DDAVP transiently improves hemostasis in Bernard-Soulier syndrome independent of von-WillebrandFactor. Ann Hematol 1993; 67: 149-50.
    CrossrefPubMedGoogle Scholar
  • 8 Linden MD, FrelingerA L, Barnard MR. et al. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004; 30: 501-11.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Carreras E. Early Complications after HSCT. In: The EBMT Handbook. Haematopoietic Stem Cell Transplantation. Apperly J, Carreras E, Gluckman E, Gratwohl A, Masszi T. 2004. Revised Edition. Forum Service Editore; Genua: 2004: 133-45.
    Google Scholar
  • 10 Locatelli F, Rossi G, Balduini C. Hematopoietic stem-cell transplantation for the Bernard-Soulier-Syndrome. Ann Int Med 2003; 138: 79.
    PubMedGoogle Scholar